Τόμος 18 (2000) – Τεύχος 1 – Άρθρο 1 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 18 (2000) – Issue 1 – Article 1 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Κωνσταντίνος Λ. Παπαδόπουλος¹, Βασίλης Κόκκας², Αλεξάνδρα Μισσοπούλου³

¹ Β΄ Καρδιολογική Κλινική, ² Εργαστήριο Φαρμακολογίας και ³ Εργαστήριο Βιοχημείας, Ιατρικό Τμήμα Αριστοτελείου Πανεπιστημίου Θεσσαλονίκης, Θεσσαλονίκη, Ελλάς

C.L.  Papadopoulos¹, B. Kokkas², A. Mis­sopoulou³

¹ Department of 2^nd Cardiology, ² Department of Pharmacology and ³ Department of Bio­chemistry, Medical School, Aristotle Uni­versity, Thessaloniki, Greece

2. Holum J.: Fundamentals of general, organic and bio­logi­cal chemistry. Wiley J. and Sons, New York 1994

3. Packard C.J: Plasma lipid and lipoprotein metabolism in the 1990s – what we know and what we need to know. In: (Betteridge D.J., ed.): Lipids: Current Perspectives. Vol 1 Lipids and lipoproteins, Martin Dunitz, London, 1-20, 1996

4. Horton J., Shimomura I.: Sterol regulatory element-bind­ing proteins; activators of cholesterol and fatty acid bio­synthesis. Cur. Opin. Lipidol. 10: 143-150 (1999)

5. Linton Mac R.F., Fazio S.: Macrophages, lipoprotein metabolism, and atherosclerosis, Curr. Opin. Lipidol 10: 97-105 (1999)

6. Ross R.: The pathogenesis of atherosclerosis. Nature 362: 801-809 (1993)

7. Spangenberg J., Curtis L.: Influence of macrophage derived apoprotein-E on plasma lipoprotein distribution of apolipoprotein-AI in apoprotein-E deficient mice. Bio­chim. Biophys. Acta 1349: 109-121 (1997)

8. Fazio S., Linton M.: Murine bone marrow transplanta­tion as a novel approach to studying the role of macro­phages in lipoprotein metabolism and atherogenesis. Trends Car­dio­vasc. Med. 6: 58-65 (1996)

9. Chapman MJ, Guerin M, Bruckert E.: Atherogenic, dense low – density lipoproteins. Pathophysiology and new therapeutic approaches. Eur. Heart J. 19 (Suppl A): A24-A30 (1998)

10. Torra I.P., Genois Ph., Staels B.: Peroxisome prolif­erator-activated receptor alpha in metabolic disease, in­flammation, atherosclerosis and aging. Curr. Opin. Lipi­dol. 10: 151-159 (1999)

11. Ares M., Nilsson J.: Atherosclerosis; Cell biology and lipoproteins. Curr. Opin. Lipidol. 10: 191-192 (1999)

12. Jerome W., Cash C., Webber R., Horton R., Yancey P.: Lysosomal lipid accumulation from oxidized low den­sity lipoprotein is correlated with hypertrophy of the Golgi appa­ratus and trans-Golgi network. J. Lip. Res. 39: 1362-1371 (1998)

13. Bjorkhem J., Diczfalusy U., Lutjohann D.: Removal of Cholesterol from extrahepatic sources by oxidative mecha­nism, Curr. Opin. Lipidol. 10: 161-165 (1999)

14. Babiker A., Andersson O., Lund E., Xiu R., Deeb S., Reshef A.: Elimination of cholesterol in macrophages and endothelial cells by the sterol- 27- hydroxylase mecha­nism. J. Biol. Chem. 272: :26253-26261 (1997)

15. Lund E., Andersson O., Zhang J., Babiker A., Diczfa­lusy U., Ahlborg G.: Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans. Arterioscler. Thromb. Vasc. Biol. 16: 208-212 (1996)

16. Crisby M., Nilsson J., Kostulas V., Bjorkhem I., Dic­zfa­lusy U.: Location of sterol 27-hydroxylase immunore­activity in human atherosclerotic plaques. Biochim. Bio­phys. Acta 1344: 278-285 (1997)

17. Bjorkhem I., Lutjohann D., Breuer O., Sakinis A., Wennmalm A.: Importance of a novel oxidative mecha­nism for elimination of brain cholesterol. J. Biol. Chem. 272: 30178-30184 (1997)

18. Papadopoulos V.: Peripheral – type benzodiazepine / diazepam binding inhibitor receptor: Biological role in ster­oidogenic cell function. Endocrine Rev. 14: 222-234 (1993)

19. Deegam P, Feely J.: Making sensible drug choices – horses for courses. In: (Betteridge D.J., ed) Lipids: Cur­rent Perspectives. Vol 3 Management, Lipids and lipo­proteins, Martin Dunitz, London, 227-245, 1996

20. Witzum J.: Drugs used in the treatment of hyperlipo­proteinemias. In: (Hardman J. and Limbird L., eds) Good­man and Gilman’s. The pharmacological basis of thera­peu­tics. pp 875-897, McGraw-Hill, New York, 1996

21. Richard B., Pfeuffer M., Pittman R.: Transport of HDL-cholesterol ester to the liver is not diminished by probucol treatment in rats. Arterioscl. Thromb. 12: 862-869 (1992)

22. Kushvaha R., Guntupalli B., Rice K., Carey K., McGill H.: Effect of dietary cholesterol and fat on the expression of hepatic cholesterol 27-hydroxylase and other hepatic cho­lesterol responsive genes in baboons. Atherioscler. Thromb. Vasc. Biol. 15: 1404-1411 (1995)